Skip to main content

MoneyWorks4Me

Windlas Biotech informs about transcript of earnings call

13 Nov 2026 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Windlas Biotech has informed that it attached Q2 & H1 FY27 Earnings Conference Call Transcript.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1889.40
Dr. Reddys Labs. 1385.55
Cipla 1409.00
Lupin 1983.20
Zydus Lifesciences 1190.10
View more..